Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juan M. Hernandez-Meza"'
Autor:
Kanchan Chauhan, Juan M. Hernandez-Meza, Ana G. Rodríguez-Hernández, Karla Juarez-Moreno, Prakhar Sengar, Rafael Vazquez-Duhalt
Publikováno v:
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-14 (2018)
Abstract Background Tamoxifen is the standard endocrine therapy for breast cancers, which require metabolic activation by cytochrome P450 enzymes (CYP). However, the lower and variable concentrations of CYP activity at the tumor remain major bottlene
Externí odkaz:
https://doaj.org/article/fde4e330e7694160a0c53e4d05ed2b9c
Publikováno v:
Journal of Chemical Information and Modeling. 61:2328-2340
Inhibition of the expression of the human ether-a-go-go (hEAG1 or hKV10.1) channel is associated with a dramatic reduction in the growth of several cancerous tumors. The modulation of this channel’...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00d8329217f65c3536103f95878d81c6
https://doi.org/10.1021/acs.jcim.0c01353
https://doi.org/10.1021/acs.jcim.0c01353
Autor:
Juan M. Hernandez-Meza, Rafael Vazquez-Duhalt, Kanchan Chauhan, Prakhar Sengar, Karla Juarez-Moreno, Ana G. Rodríguez-Hernández
Publikováno v:
Journal of Nanobiotechnology
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-14 (2018)
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-14 (2018)
Background Tamoxifen is the standard endocrine therapy for breast cancers, which require metabolic activation by cytochrome P450 enzymes (CYP). However, the lower and variable concentrations of CYP activity at the tumor remain major bottlenecks for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5fdff753c61a70ace62cef32788615c
https://pubmed.ncbi.nlm.nih.gov/29463260
https://pubmed.ncbi.nlm.nih.gov/29463260